Gita Thanarajasingam

Dr. Gita Thanarajasingam is an Associate Professor of Medicine and consultant in the Division of Hematology at Mayo Clinic in Rochester, MN, USA. Her clinical practice is focused on Hodgkin and non-Hodgkin lymphoma, and she performs health outcomes research in cancer.  Her research program focuses on improving the evaluation of adverse events of treatment and measuring their impact on treatment tolerability in cancer patients. She developed Toxicity over Time (ToxT), a longitudinal patient-focused approach to adverse event evaluation. She serves of as vice co-chair of the Alliance Health Outcomes Committee and is the recipient of K and U01 grants from the U.S. National Institutes of Health (NIH). Dr. Thanarajasingam is a graduate of Yale University, Mayo Clinic Alix School of Medicine and the Brigham and Women’s Hospital at Harvard Medical School.